Verastem (VSTM) Interest Coverage Ratio Growth (3y) (2020 - 2026)
Powered by 
Analysis
Verastem (VSTM) Interest Coverage Ratio Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | -44.22% |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 33.30% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -35.50% |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 81.16% |
| 10 | Verastem | 815.85 Mn | 679.49 Mn | 36.32 Mn | -71.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -71.22% |
| Mar 31, 2026 | -67.18% |
| Dec 31, 2025 | -62.55% |
| Sep 30, 2025 | -72.89% |
| Jun 30, 2025 | -83.44% |
| Mar 31, 2025 | 8.79% |
| Dec 31, 2024 | 74.44% |
| Sep 30, 2024 | -158.82% |
| Jun 30, 2024 | -0.48% |
| Mar 31, 2024 | -19.72% |
| Dec 31, 2023 | -30.98% |
| Sep 30, 2023 | -63.68% |
| Jun 30, 2023 | -16.72% |
| Mar 31, 2023 | -116.77% |
| Dec 31, 2022 | -56.20% |
| Sep 30, 2022 | -68.33% |
| Jun 30, 2022 | -65.46% |
| Mar 31, 2022 | -250.63% |
| Dec 31, 2021 | -475.36% |
| Sep 30, 2021 | 57.95% |